Key result
Higher SPISE index linked to ~37% lower odds of prevalent AF, outperforming TyG index.
Why the study?
Insulin resistance is a common pathogenic mediator of CHD and AF, but the comparative predictive capacities of SPISE and TyG indices for AF in CHD patients are unclear.
Does the SPISE index improve prediction of prevalent atrial fibrillation compared to the TyG index in patients with coronary heart disease?
Cohort (n=515)
No
Does the SPISE index improve prediction of prevalent atrial fibrillation compared to the TyG index in patients with coronary heart disease?
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for SPISE in AF risk stratification among CAD patients; prospective validation needed before clinical adoption.
Objective Insulin resistance (IR) acts as a common pathogenic mediator underlying both coronary heart disease (CHD) and atrial fibrillation (AF). The Single-Point Insulin Sensitivity Estimator (SPISE index) and triglyceride-glucose (TyG) index are two readily available laboratory surrogates for IR. This study sought to compare their independent predictive capacities for concomitant AF among patients with CHD. Methods Baseline clinical data and laboratory measurements were collected to calculate SPISE index and the TyG index. All enrolled patients were stratified into AF and non-AF groups according to their baseline cardiac rhythm. Intergroup comparisons of the two metabolic biomarkers were conducted. Univariate and multivariate logistic regression models were constructed to identify independent correlates of AF. Restricted cubic spline (RCS) modeling was utilized to explore the nonlinear association between SPISE index and AF. Receiver operating characteristic (ROC) curve analysis was performed to quantify and compare the predictive capacity of SPISE index and the TyG index for AF. Predefined subgroup analyses were further carried out to evaluate potential effect modification across clinical strata. Results SPISE index levels were significantly higher in the non-AF group relative to the AF group ( P < 0.001). After comprehensive adjustment for all confounding covariates, SPISE index was independently inversely associated with prevalent AF (OR = 0.627, 95% CI: 0.528–0.746, P < 0.001). Restricted cubic spline combined with segmented regression analyses identified a significant nonlinear association between SPISE index and AF with a distinct inflection point. ROC curve analysis demonstrated that SPISE index exhibited superior predictive performance for AF risk compared with the TyG index (AUC: 0.646 vs. 0.566). The difference in AUC values between the two markers reached statistical significance according to Delong’s test. Stratified subgroup analyses revealed that the inverse correlation between SPISE index and prevalent AF remained stable across all predefined strata, including sex, age, smoking status, alcohol consumption, hypertension, diabetes mellitus, and BMI. Conclusion SPISE index represents an independent correlate of prevalent AF in CHD patients. Compared with the TyG index, this convenient insulin sensitivity biomarker possesses superior screening value for identifying CHD individuals with concomitant AF.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Coronary artery disease (CHD) with or without prevalent atrial fibrillation (n=515). SPISE index vs. TyG index was evaluated on Prevalent atrial fibrillation (OR 0.627, 95% CI 0.528-0.746, p=<0.001). Higher SPISE index was independently inversely associated with prevalent atrial fibrillation (OR 0.627) and exhibited superior predictive performance compared with the TyG index.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: